| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PLoSO..1039008G |
| P356 | DOI | 10.1371/JOURNAL.PONE.0139008 |
| P932 | PMC publication ID | 4583481 |
| P698 | PubMed publication ID | 26407166 |
| P5875 | ResearchGate publication ID | 282291587 |
| P50 | author | Leslie A Kirby | Q84494521 |
| Justin D Glenn | Q39186971 | ||
| Matthew D Smith | Q39186985 | ||
| P2093 | author name string | Katharine A Whartenby | |
| Emily G Baxi | |||
| P2860 | cites work | Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Q29618769 |
| CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis | Q30493331 | ||
| Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner | Q33438830 | ||
| Autoimmune T cell responses in the central nervous system | Q33620003 | ||
| A novel pancreatic β-cell targeting bispecific-antibody (BsAb) can prevent the development of type 1 diabetes in NOD mice | Q33829266 | ||
| Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression | Q33898626 | ||
| The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. | Q34122755 | ||
| Mesenchymal stem cells lack efficacy in the treatment of experimental autoimmune neuritis despite in vitro inhibition of T-cell proliferation | Q34168051 | ||
| Characterization of oligodendroglial populations in mouse demyelinating disease using flow cytometry: clues for MS pathogenesis | Q34232425 | ||
| Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy | Q34259085 | ||
| Antigen-specific splenic CD4+ and CD8+ regulatory T cells generated via the eye, suppress experimental autoimmune encephalomyelitis either at the priming or at the effector phase | Q34538693 | ||
| Promotion of remyelination by adipose mesenchymal stem cell transplantation in a cuprizone model of multiple sclerosis | Q34828914 | ||
| Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis. | Q50524244 | ||
| Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. | Q50767537 | ||
| Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor. | Q51002334 | ||
| Mesenchymal stromal cells inhibit Th17 but not regulatory T-cell differentiation. | Q53281677 | ||
| Regulation of suppressing and activating effects of mesenchymal stem cells on the encephalitogenic potential of MBP68–86-specific lymphocytes | Q57247334 | ||
| Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide | Q61645540 | ||
| Cutting edge: in vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis | Q75424618 | ||
| Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells | Q79208808 | ||
| Immunology of multiple sclerosis | Q80426447 | ||
| EAE: imperfect but useful models of multiple sclerosis | Q83252646 | ||
| Rheumatoid arthritis: Anti-TNF and anti-IL-17 antibodies--better together! | Q85868904 | ||
| Eye-mediated induction of specific immune tolerance to encephalitogenic antigens | Q86457210 | ||
| Therapeutic efficacy of three bispecific antibodies on collagen-induced arthritis mouse model | Q87819661 | ||
| Effects of murine and human bone marrow-derived mesenchymal stem cells on cuprizone induced demyelination | Q34903919 | ||
| Oral Administration of Lactococcus lactis Expressing Synthetic Genes of Myelin Antigens in Decreasing Experimental Autoimmune Encephalomyelitis in Rats | Q35717195 | ||
| Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting | Q35849125 | ||
| Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravis. | Q35899107 | ||
| IL-17-induced Act1-mediated signaling is critical for cuprizone-induced demyelination | Q36142154 | ||
| Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models. | Q36188460 | ||
| Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis | Q36254088 | ||
| Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis | Q36299392 | ||
| Signal transduction inhibition of APCs diminishes th17 and Th1 responses in experimental autoimmune encephalomyelitis | Q37055766 | ||
| IL-23 promotes maintenance but not commitment to the Th17 lineage | Q37183888 | ||
| Peptide-based immunotherapy of experimental autoimmune encephalomyelitis without anaphylaxis | Q37235161 | ||
| Growth of a rat neuroblastoma cell line in serum-free supplemented medium | Q37313160 | ||
| Multiple sclerosis - candidate mechanisms underlying CNS atrophy | Q37691873 | ||
| Mesenchymal Stem Cells: Mechanisms of Inflammation | Q37809081 | ||
| Adult mesenchymal stem cell therapy for myelin repair in multiple sclerosis. | Q38071231 | ||
| Peptide immunotherapy in experimental autoimmune encephalomyelitis | Q38525786 | ||
| Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitis | Q39178437 | ||
| Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. | Q39698715 | ||
| Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo | Q39823115 | ||
| Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo | Q40662801 | ||
| Mesenchymal stromal-cell transplants induce oligodendrocyte progenitor migration and remyelination in a chronic demyelination model. | Q41790153 | ||
| A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. | Q42767100 | ||
| Human mesenchymal stem cells infiltrate the spinal cord, reduce demyelination, and localize to white matter lesions in experimental autoimmune encephalomyelitis. | Q43578851 | ||
| The in vivo and in vitro induction of anterior chamber associated immune deviation to myelin antigens in C57BL/6 mice | Q44999687 | ||
| In vitro-induced cell-mediated immune deviation to encephalitogenic antigens | Q46340968 | ||
| Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice | Q48151907 | ||
| Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice | Q48497239 | ||
| Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone | Q48633695 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | experimental autoimmune encephalomyelitis | Q494066 |
| mesenchymal stem cell | Q1922379 | ||
| cuprizone | Q27262585 | ||
| P304 | page(s) | e0139008 | |
| P577 | publication date | 2015-09-25 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Disparate Effects of Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis and Cuprizone-Induced Demyelination | |
| P478 | volume | 10 |
| Q28595492 | Intravenous transplantation of mouse embryonic stem cells attenuates demyelination in an ICR outbred mouse model of demyelinating diseases |
| Q64230072 | Potential Therapeutic Features of Human Amniotic Mesenchymal Stem Cells in Multiple Sclerosis: Immunomodulation, Inflammation Suppression, Angiogenesis Promotion, Oxidative Stress Inhibition, Neurogenesis Induction, MMPs Regulation, and Remyelination |
Search more.